This inventor holds 1 USPTO granted patent and 8 published patent applications and 3 EPO patents. Top assignee: Csl Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Adriana Baz Morelli: Innovator in Biopharmaceuticals
Introduction: Adriana Baz Morelli is a notable inventor based in Carlton, Victoria, Australia. She is currently associated with CSL Limited, a leading global biotechnology company. Adriana has made significant contributions to the field of biopharmaceuticals, particularly in the area of blood coagulation.
Latest Patent Applications: Adriana's latest patent application is titled "Polypeptides for Inducing Tolerance to Factor VIII." This invention relates to polypeptides that comprise a von Willebrand factor (VWF) moiety and an erythrocyte-binding moiety. The polypeptide is designed to bind to blood coagulation factor VIII (FVIII). The erythrocyte-binding moiety may include a peptide ligand, an antibody, an antibody fragment, or a single chain antigen binding domain (scFv). These polypeptides can be provided as a heterodimer and are useful for inducing tolerance to FVIII.
Conclusion: Adriana Baz Morelli is an innovative inventor whose work in biopharmaceuticals has the potential to impact the treatment of blood coagulation disorders. Her contributions to the field are noteworthy, and her ongoing research continues to advance medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile